Panbela Therapeutics, Inc.
PBLA · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $2,578 | $1,285 | $11,867 | $9,022 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $183 | $49 | $321 | $323 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $299 | $443 | $91 | $412 |
| Total Curr. Assets | $3,060 | $1,777 | $12,279 | $9,757 |
| Property Plant & Equip (Net) | $0 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $8,742 | $3,201 | $593 | $56 |
| Total NC Assets | $8,742 | $3,201 | $593 | $56 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $11,802 | $4,978 | $12,872 | $9,813 |
| Liabilities | – | – | – | – |
| Payables | $9,939 | $2,865 | $640 | $554 |
| Short-Term Debt | $1,000 | $1,650 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $1,379 | $3,318 | $2,020 | $811 |
| Total Curr. Liab. | $12,318 | $7,833 | $2,660 | $1,365 |
| LT Debt | $4,194 | $5,194 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $4,194 | $5,194 | $640 | $0 |
| Other Liabilities | $0 | $0 | -$640 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $16,512 | $13,027 | $2,660 | $1,365 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $1 | $13 | $10 |
| Retained Earnings | -$125,497 | -$91,094 | -$56,161 | -$46,026 |
| AOCI | $745 | $759 | $133 | -$384 |
| Other Equity | $120,042 | $82,285 | $66,240 | $54,848 |
| Total Equity | -$4,710 | -$8,049 | $10,212 | $8,448 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $11,802 | $4,978 | $12,872 | $9,813 |
| Net Debt | $2,616 | $5,559 | -$11,867 | -$9,022 |